Noosa News
Brisbane company wins European approval for rapid COVID-19 tests
A Brisbane-based firm has won approval from European regulators to sell its 15-minute COVID-19 rapid test.
The company, AnteoTech, has been given the Conformitè Europëenne Mark registration for its antigen rapid test, EuGeni.
AnteoTech chief executive Derek Thomson.
The reusable test, which now meets crucial health and safety conditions in Europe and the United Kingdom, is expected to be used in mass testing programs such as concerts and sporting events.
The tests have not been approved for use in Australia.
AnteoTech chief executive Derek Thomson said he was “leverage opportunities that lie ahead of us”.
“CE Mark registration for the COVID-19 antigen rapid test platform provides AnteoTech with an opportunity to capture some of the…
-
General13 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General16 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
General21 hours agoPrincess Diana enters Paris waxwork museum in ‘revenge dress’
-
General15 hours agoGold Coast and Noosa councils scammed out of ratepayers’ money